IGHE and breast neoplasm: IgE/antigen-activated mast cells may release mediators such as CCL2, CCL3, CCL7, and CCL8 among others (Figure 1) that facilitate inflammatory innate reactions and subsequently promote adaptive immunity against breast tumors.